ENGLEWOOD, CO -- (Marketwire) -- 11/05/10 -- Evolving Systems, Inc. (NASDAQ: EVOL), a leading provider of software solutions and services to the wireless, wireline and cable markets, today announced that CEO Thad Dupper and CFO Brian Ervine will present at the 40th Annual AeA Classic Financial Conference presented by TechAmerica in San Diego, CA, on Tuesday, November 9, 2010.
The Company's presentation material will be made available on November 7, 2010, at www.evolving.com
About Evolving Systems
Evolving Systems, Inc. (NASDAQ: EVOL) ... read more
National Semiconductor Corp. (NYSE: NSM) has won the Silicon Valley Business Journal's Corporate Philanthropy Impact Award. The award acknowledges National's efforts to enhance science and math curriculum, particularly through the company's long-standing partnership with the Santa Clara Unified School District (SCUSD).
Over 15 years, National has provided grants to SCUSD, Resource Area for Teaching (RAFT) and the Santa Clara County Office of Education to train teachers with a goal of enhancing hands-on science and in-classroom technology initiatives. The company recently ... read more
Pervasis Therapeutics, Inc. today announced that it has been awarded over $920,000 in grants through the U.S. government's Qualifying Therapeutic Discovery Project, which provides tax credits and grants to projects that show significant potential to produce new therapies, reduce long-term health care costs, or significantly advance the goal of curing cancer within the next 30 years.
Pervasis is a clinical stage company focused on developing breakthrough therapies with the potential to improve outcomes following common vascular surgical and interventional procedures, such ... read more
Amgen (Nasdaq: AMGN) is pleased to announce that it has won the Best New Drug award for Prolia(TM) (denosumab), a novel treatment approved in the United States (U.S.) for women with postmenopausal osteoporosis at high risk for fracture, at the 2010 Scrip Awards ceremony Nov. 4 in London. Named one of TIME's Top 10 Medical Breakthroughs of 2009, Prolia is the first treatment specifically designed to target osteoclasts, the cells that break down bone.
In addition to its novel mechanism of ... read more
Sermo (http://www.sermo.com), the world's largest online community for physicians, today announced a free Sermo Report titled, "Treatment Options for Gout". The report gathered feedback from physicians to better understand how they currently treat gout and if they would consider using new treatments.
While many physicians who participated felt that current gout treatments effectively manage acute and suppressed gout flares, 63% confirmed they would utilize new gout medications as they become available. Physicians also listed many different patient types that would ... read more
United American Healthcare Corporation (OTCQB: UAHC) today announced that its Board of Directors has approved key appointments to the Company's senior management team. UAHC management also announced that the Company will relocate its headquarters from Detroit to Chicago.
-- John M. Fife, Chairman of the Board, has been named President and CEO of
UAHC, succeeding William C. Brooks, who will continue to serve on the
... read more
Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Donald Wood, chief operations officer, will present at the Sidoti & Company Third Annual New York Conference II on Monday, November 15, 2010 at 11:20 a.m. ET. The conference will be held at the Grand Hyatt Hotel in New York City.
Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid ... read more
A class of compounds that interferes with cell signaling pathways may provide a new approach to cancer treatment, according to a study published online this week in the Proceedings of the National Academy of Sciences (PNAS) Early Edition. The compounds, called PITs (non-phosphoinositide PIP3 inhibitors), limited tumor growth in mice by inducing cell death.
"PITs cause cells to self-destruct by interfering with the signaling pathways that regulate cell survival. As compounds that promote cell death, PITs show promise in halting ... read more
From 10 a.m. to 5 p.m., on Friday, November 5, Cox will hold a job fair at the Pembroke Mall in Virginia Beach.
Cox is seeking employees with previous technology sales experience. "On-the-spot" interviews will be conducted during the day.
Features of the position opportunities include:
-- Earn base pay & commissions
-- High income potential
-- Competitive pay and benefits
-- Free/discounted Cox services
For more ... read more
Advanced Photonix (API) today announced an agreement in principle with In-Q-Tel (IQT) to engineer a low cost terahertz anomaly detection device, and deliver multiple systems for evaluation. IQT, a not-for-profit, strategic investment firm that works on behalf of the U.S. Intelligence Community, is focused on identifying new and emerging commercial technologies that have the potential to give its customer agencies mission-advantage today and in the future.
"We are excited to have reached an agreement in principle with IQT ... read more
Activision Blizzard, Inc. (Nasdaq: ATVI) today announced that Thomas Tippl, Chief Operating Officer of Activision Blizzard, Inc., will be presenting at the BMO Capital Markets 18th Annual Digital Entertainment Conference on Thursday, November 11 at 9:00 am (ET) at the Grand Hyatt Hotel in New York City.
Mr. Tippl's remarks will be broadcast over the Internet. To access the webcast, please log on to www.activisionblizzard.com or:
Please note that the presentation time is subject to change. Please contact the financial ... read more
Conn’s, Inc. (NASDAQ/NM:CONN), a specialty retailer of consumer
electronics, home appliances, furniture, mattresses, computers and lawn
and garden products, today announced its net sales results for the
quarter ended October 31, 2010.
Net sales for the quarter ended October ... read more
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT,
a development-stage oncology and dermatology biopharmaceutical company,
presented positive preliminary data from fully monitored study data for
the entire study population of 80 subjects in its Phase 2 clinical trial
of PV-10 for ... read more
Inc. (NASDAQ:MVIS), a leader in innovative ultra-miniature
projection display technology, today announced it has purchased a
significant patent portfolio from Motorola, Inc. that will extend the
company’s intellectual property leadership in pico projection and
... read more
Kimball International, Inc. (NASDAQ: KBALB) today reported net sales of
$294.7 million and net income of $0.5 million, or $0.01 per Class B
diluted share, for the first quarter of fiscal year 2011 which ended
September 30, 2010. Net income for the fiscal year 2011 first quarter
... read more
Asankya, Inc., the leader in application delivery networking for network intensive applications, announced today the issuance by the U.S. Patent and Trademark Office of a patent for improving transport protocols. The Patent is a complement to Asankya's other technology features, which together provide end-to-end network performance optimization. This patent is crucial to protecting the core algorithms of the Asankya products and services.
The U.S. Patent (App. No. 11/672,390) relates to intelligent transport-layer ... read more
CIBER (NYSE: CBR), a global consulting, services and outsourcing company, today announced a partnership with Alterian (LSE: ALN), the leader in customer engagement technology and solutions.
The partnership allows CIBER to offer a solution to its clients that integrates the CIBER Unified Digital Marketing Model (UDMM) framework with Alterian's market-leading Customer Engagement platform. This equips CIBER clients, who use the UDMM framework to facilitate the delivery, support and management of digital marketing websites and campaigns, with faster ... read more
John Purvis has been named Vice President of Small Tactical Unmanned Air Systems (STUAS) at AeroMech Engineering, Inc. (AME). The announcement was made today by Jay McConville, President and CEO of AME.
In making the announcement, Mr. McConville said: "We are very pleased to have John Purvis on the AME Team. John is an experienced executive who knows how to develop and deliver complex ISR and IEW systems to our defense customers, and he will bring that experience to the fielding ... read more
Tomophase Corporation, a leading developer of minimally invasive optical coherence tomography (OCT) tissue imaging devices, announced that it has received an award from the Departments of the Treasury and Health and Human Services for the Qualifying Therapeutic Discovery Project (QTDP.)
The Qualifying Therapeutic Discovery Project is a federally sponsored program that is targeted to projects that show a reasonable potential to:
-- Result in new therapies to treat areas of unmet medical need or prevent,
... read more